Number of Reactions(Preps)/Kit : 50
Brand : SD
ICMR Approved : Yes
Result Time (Rapid Kits) : 15 min
Sample Type : Oral & Nasal Swab
STANDARD E Dengue IgM ELISA analyzes IgM antibodies specific to Dengue virus in serum and plasma using enzyme linked immunosorbent assay.
Number of Reactions(Preps)/Kit : 96 Wells
Brand : InBios
Sample Material : Serum
Format : ELISA
Incubation Time : 30 + 30 + 5 + 10 + 1
Cat No : STMS-R
The Scrub Typhus Detect IgM ELISA for exposure to Orientia tsutsugamushi (OT; formerly Rickettsia) is an ELISA system for the detection of IgM antibodies in human serum to OT-derived recombinant antigen. This test is for research use only. Not for use in diagnostic procedures.
The complete kit includes one 96 well strippable plate with all necessary reagents and controls.
Product Details:
Number of Reactions(Preps)/Kit ; 96 Wells
Brand : InBios
Format : Immunocapture
Specimen : Serum
Cat No : ZKM2-1
The ZIKV Detect 2.0 IgM Capture ELISA is intended for the qualitative detection of Zika virus IgM antibodies in human sera for the presumptive clinical laboratory diagnosis of Zika virus infection. The assay is intended for use only in patients with clinical signs and symptoms consistent with Zika virus infection, and/or CDC Zika virus epidemiological criteria (e.g., history of residence in or travel to a geographic region with active Zika transmission at the time of travel, or other epidemiological criteria for which Zika virus testing may be indicated). Assay results are for the presumptive detection of IgM antibodies to Zika virus (ZIKV). Positive results must be confirmed by following the latest CDC guidelines for the diagnosis of Zika virus infection.
Results of this test are intended to be used in conjunction with clinical observations, patient history, epidemiological information, and other laboratory evidence to make patient management decisions. Zika IgM levels are variable over the course of the infection and may be detectable near day four post onset of symptoms and persist up to approximately 12 weeks following initial infection.
Negative results may be seen in specimens collected before day four post onset of symptoms or after the window of detectable IgM closes, and therefore do not preclude the possibility of Zika virus infection, past or present.
1st Commercial serology kit to receive FDA Marketing Authorization
CE Marked
Differentiates Zika IgM positive patients from those infected with other flaviviruses such as West Nile or Dengue
Sensitivity: >90%
Specificity: >96%
Results in 4 hours
Tests up to 28 unknown specimens.
2631 Panbio Leptospira Igm Elisa Suppliers
Short on time? Let Panbio Leptospira Igm Elisa sellers contact you.
Number of Reactions(Preps)/Kit : 96 Wells
Brand : InBios
Sample Material : Serum
Incubation Time: 60+60+60+5+10+1
Storage 2-8 C
Cat No : DDMS-1
The DENV DetectTM IgM Capture ELISA is for the qualitative detection of IgM antibodies to DENV recombinant antigens in serum for the presumptive clinical laboratory diagnosis of Dengue virus infection. The assay is intended for use only in patients with clinical symptoms consistent with either dengue fever or dengue hemorrhagic fever.
The complete kit includes one 96 well strippable plate with all necessary reagents and controls.
1st Assay to Receive FDA Clearance.
Performance thoroughly evaluated with clinically confirmed cases of dengue 1-4 serotypes.
Excellent positive and negative agreement with WHO reference panel (>90%).
Improves accuracy by monitoring background reactivity with a normal cell antigen.
Employs a simple, one step ratio method of interpretation.
CE Marked.
The Varicella-Zoster Virus (VZV) IgM ELISA is intended for the qualitative determination of IgM class antibodies against Varicella-Zoster Virus (VZV) in human serum or plasma (citrate, heparin).
Product Name:
Surplex(R)-COVID-19 IgM/IgG Rapid test
Product Description:
Surplex(R)-COVID-19 IgM/IgG Rapid test is a serology test intended for the qualitative detection of IgM and IgG antibodies of the novel coronavirus (the SARS-COV-2 virus) in human serum, plasma or whole blood. It is CE marked and approved in Brazil (ANVISA approved).
We are motivated to aggressively price our product and ready to send 20 tests (one box) to qualified buyers for evaluation, free of charge.
Price of product:
FOB USD $1.50 - $2.50 per test, volume dependent.
Product origin :
China.
Key Specifications/Special Features :
- Competitively priced and ready to ship in volume.
- Currently shipping in volume to Brazil.
- Highly accurate and specific - performance independently confirmed.
- Results ready in 15 minutes.
- Harmonization System (HS) Code: 382200.
- We provide a full support during regulatory application.
Minimum Order Size and Packaging details:
MOQ: Flexible.
Box of 20 or 50 test kits.
Storage: 2-30C.
Shelf Life: 10 months.
The One Step HAV IgG/IgM Test is a rapid chromatographic immunoassay for the qualitative detection of antibodies (IgG and IgM) to Hepatitis A Virus (HAV) in Whole Blood /Serum / Plasma to aid in the diagnosis of Hepatitis A Virus.
Summary
Hepatitis A is an acute, usually self-limiting disease of the liver caused by hepatitis A virus (HAV). HAV is transmitted from person to person, primarily by the faecal-oral route. The incidence of hepatitis A is closely related to socioeconomic development, and seroepidemiological studies show that prevalence of anti-HAV antibodies in the general population varies from 15% to close to 100% in different parts of the world. One step HAV IgG/IgM Test is a simple, visual qualitative test that detects Hepatitis A Virus antibodies in human Whole Blood /Serum / Plasma. The test is based on immunochromatography and can give a result within 15 minutes.
Principle
The One Step HAV IgG/IgM Test is a qualitative membrane strip based immunoassay for the detection of Hepatitis A Virus antibodies (IgG and IgM) in Whole Blood /Serum / Plasma. The test device consists of: 1) a burgundy colored conjugate pad containing HAV recombinant envelope antigens conjugated with Colloid gold (HAV conjugates) and rabbit IgG-gold conjugates,2) a nitrocellulose membrane strip containing two test bands (T1 and T2 bands) and a control band (C band). The T1 band is pre-coated with the antibody for the detection of IgM anti-HAV, T2 band is coated with antibody for the detection of IgG anti-HAV, and the C band is pre-coated with goat anti rabbit IgG. When an adequate volume of test specimen is dispensed into the sample well of the test cassette, the specimen migrates by capillary action across the cassette. IgG anti-HAV, if present in the specimen, will bind to the HAV conjugates. The immunocomplex is then captured by the reagent pre-coated on the T2 band, forming a burgundy colored T2 band, indicating a HAV IgG positive test result and suggesting a recent or repeat infection. IgM anti-HAV if present in the specimen will bind to the HAV conjugates. The immunocomplex is then captured by the reagent coated on the T1 band, forming a burgundy colored T1 band, indicating a HAV IgM positive test result and suggesting a fresh infection. Absence of any T bands (T1 and T2) suggests a negative result. The test contains an internal control (C band) which should exhibit a burgundy colored band of the immunocomplex of goat anti rabbit IgG/rabbit IgG-gold conjugate regardless of the color development on any of the T bands. Otherwise, the test result is invalid and the specimen must be retested with another device.
Storage and Stability
Store as packaged in the sealed pouch at room temperature or refrigerated (4-30 or 40-86). The test device is stable through the expiration date printed on the sealed pouch.
The test must remain in the sealed pouch until use.
The Typhoid IgG/IgM Rapid Test is a lateral flow immunoassay for the simultaneous detection and differentiation of anti-Salmonella typhi (S. typhi)G and IgM in human serum or plasma. It is intended to be used as a screening test and as an aid in the diagnosis of infection with S. typhi. Any reactive specimen with the Typhoid IgG/IgM 2.0 Rapid Test must be confirmed with alternative testing method(s).
The Herpes Simplex Virus Rapid Test is a rapid qualitative lateral flow test designed for the quantitive detection of IgG antibodies to Herpes Simplex Virus (HSV) in human serum/plasma samples.
HSV-1 is usually associated with infection in oropharyngeal area and eyes, while HSV-2 causes mostly genital and neonatal infections (5, 6), however, the tissue specificity is not absolute (7). HSV-2 can be isolated occasionally from the oropharynx and 5-10% of primary genital infections may be caused by HSV-1. Infants infected with HSV appear normal at birth, but almost invariably develop symptoms during the newborn period (5, 8, 9). Neonatal HSV infection may remain localized or become disseminated. Localized infection may involve one or a combination of sites. These are skin, eyes, mouth or the central nervous system. Disseminated infection is manifested by pneumonitis, hepatitis, disseminated intravascular coagulopathy and encephalitis. Of the infants with neonatal HSV, about one half of those surviving will develop severe neurological or ocular sequelae. A number of serological procedures have been developed to detect antibodies to HSV. These include complement fixation, indirect immunofluorescent antibody, plaque neutralization, and ELISA (6, 8, 10). Antibody of the IgG class is produced during the first 2-3 weeks of infection with HSV and exists only transiently in most patients. Serologic procedures, which measure the presence of IgG antibodies, help discriminate between primary and recurrent infections, since IgG antibodies is rarely found in recurrent infections. High affinity IgG antibodies to HSV, if present in a sample, may interfere with the detection of IgG specific antibody (9). High affinity IgG antibody may preferentially bind to HSV-1 antigen leading to false negative IgG results. Also, rheumatoid factor, if present, along with antigen specific IgG, may bind to IgG causing false positive IgG results. Both problems can be eliminated by deactivating IgG in the sample before testing for IgG.
The Cytomegalovirus Rapid Test is a rapid qualitative lateral flow test designed for the quantitive detection of Cytomegalovirus (CMV) in human serum/plasma samples.
Cytomegalovirus is a herpes virus and a leading biological factor causing congenital abnormalities and complications among those who receive massive blood transfusions and immunosuppressive therapy. About half of the number of pregnant women who contract a primary infection, spread the disease to their fetus. When acquired in-utero, the infection may cause mental retardation, blindness, and/or deafness. Serological tests for detecting the presence of antibody to CMV can provide valuable information regarding the history of previous infection, diagnosis or active or recent infection, as well as in screening blood for transfusions in newborns and immuno-compromised recipients.
The Cytomegalovirus Rapid Test Device (Serum/Plasma) has been designed to detect CMV through visual interpretation of color development in the internal strip. The membrane was immobilized with antigens of CMV on the test region. During the test, the specimen is allowed to react with colored recombinant mouse anti-human IgM latex conjugates, which were precoated on the sample pad of the test. The mixture then moves on the membrane by a capillary action, and interact with reagents on the membrane. If there were enough CMV antibodies in specimens, a colored band will from at the test region of the membrane. Presence of this colored band indicates a positive result, while its absence indicates a negative result. Appearance of a colored band at the control region serves as a procedural control. This indicates that proper volume of specimen has been added and membrane wicking has occurred.
THE ONE STEP ANTI-DENGUE (IGM & IGG) TRI-LINE TEST IS A COLLOIDAL GOLD ENHANCED, RAPID IMMUNOCHROMATOGRAPHIC ASSAY FOR THE QUALITATIVE DETECTION OF ANTIBODIES (IGM & IGG) TO DENGUE VIRUS (DV) IN HUMAN WHOLE BLOOD, SERUM OR PLASMA. THIS TEST IS A SCREENING TEST, AND ALL POSITIVES MUST BE CONFIRMED USING AN ALTERNATE TEST SUCH AS WESTERN BLOT. THE TEST IS INTENDED FOR HEALTHCARE PROFESSIONAL USE ONLY.
The one step anti-dengue (igm & igg) tri-line test is a colloidal gold enhanced, rapid immunochromatographic assay for the qualitative detection of antibodies (igm & igg) to dengue virus (dv) in human whole blood, serum or plasma. This test is a screening test, and all positives must be confirmed using an alternate test such as western blot. The test is intended for healthcare professional use only.
The One Step RV IgG/IgM Test is a rapid chromatographic immunoassay for the qualitative detection of antibodies (IgG and IgM) to Rubella (Virus) in Whole Blood /Serum / Plasma to aid in the diagnosis of RV infection. The test is based on immunochromatography and can give a result within 15 minutes.
PRINCIPLE
The One Step RV IgG/IgM Test is a qualitative membrane strip based immunoassay for the detection of RV antibodies (IgG and IgM) in Whole Blood /Serum / Plasma. The test device consists of: 1) a burgundy colored conjugate pad containing RV recombinant envelope antigens conjugated with Colloid gold (RV conjugates) and rabbit IgG-gold conjugates,2) a nitrocellulose membrane strip containing two test bands (T1 and T2 bands) and a control band (C band). The T1 band is pre-coated with the antibody for the detection of IgM anti-RV, T2 band is coated with antibody for the detection of IgG anti-RV, and the C band is pre-coated with goat anti rabbit IgG. When an adequate volume of test specimen is dispensed into the sample well of the test cassette, the specimen migrates by capillary action across the cassette. IgG anti-RV, if present in the specimen, will bind to the RV conjugates. The immunocomplex is then captured by the reagent pre-coated on the T2 band, forming a burgundy colored T2 band, indicating a RV IgG positive test result and suggesting a recent or repeat infection. IgM anti-RV if present in the specimen will bind to the RV conjugates. The immunocomplex is then captured by the reagent coated on the T1 band, forming a burgundy colored T1 band, indicating a RV IgM positive test result and suggesting a fresh infection. Absence of any T bands (T1 and T2) suggests a negative result. The test contains an internal control (C band) which should exhibit a burgundy colored band of the immunocomplex of goat anti rabbit IgG/rabbit IgG-gold conjugate regardless of the color development on any of the T bands. Otherwise, the test result is invalid and the specimen must be retested with another device.
Storage and Stability
Store as packaged in the sealed pouch at room temperature or refrigerated (4-30â?? or 40-86â??). The test device is stable through the expiration date printed on the sealed pouch.
The test must remain in the sealed pouch until use.
The test kit utilize purified Chlamydia Trachomatis Antibody antigen, based on GIFA principle and use indirect method to detect Urea Plasma Urealyticum antibody in human serum.
TEST PROCEDURE
1. Remove the test kit and put it at room temperature (for about 20-30mins) before testing.
2. Add 1 drop of Wash Buffer into the hole and allow the liquid soak the membrane completely.
3. Add 150l of the serum specimen into the hole and allow it to sufficient absorption.
4. Add 3 drops of Colloidal Conjugate into the hole and allow it to sufficient absorption.
5. Add 3 drops of Wash Buffer into the hole and allow it to sufficient absorption. Read the results within 3 minutes.
STORAGE
The kit can be stored at room temperature (2-30C). The test kit is stable through the expiration date (18 months) marked on the foil pouch. DO NOT FREEZE. Do not store the test kit in direct sunlight.
General Information
One-Step Chikungunya IgG/IgM Rapid Test is detection of IgG and IgM anti-chikungunya virus CHIK in human blood.
Sensitivity: 90.3% , Specificity: 100%
Specimen : Serum, Plasma or Whole Blood
Reading Time : 10 min
2631 Panbio Leptospira Igm Elisa Suppliers
Short on time? Let Panbio Leptospira Igm Elisa sellers contact you.
